The Goldman Sachs Group Increases Organon & Co. (NYSE:OGN) P

Organon & Co. (NYSE:OGN – Get Free Report) had its price target upped by equities researchers at The Goldman Sachs Group from $16.00 to $18.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has a “neutral” rating on the stock. The Goldman Sachs Group’s price objective suggests a potential downside of […]

Related Keywords

United States , Massachusetts , Nexplanon Implanon , Piper Sandler , Invesco Ltd , Organon Co , Massachusetts Financial Services Co , Vanguard Group Inc , News Ratings For Organon Co , Analyst Recommendations For Organon Co , Geode Capital Management , Goldman Sachs Group , Get Free Report , Street Corp , Financial Services , Capital Management , Ganirelix Acetate Injection , Nyse Ogn , Ogn , Medical , Boost Price Target , The Goldman Sachs Group Inc ,